COMMUNIQUÉS West-GlobeNewswire

athenahealth Announces Second Quarter 2018 Earnings Conference Call
09/07/2018
WATERTOWN, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that it will hold a [...]
WellDoc®’s BlueStar® Now Available for Hypertension and Weight Management
09/07/2018
BlueStar Provides One-Stop Solution for Managing Multiple Chronic Conditions BALTIMORE, July 09, 2018 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company, today announces hypertension and weight management [...]
Cerner and Lumeris Will Launch Offering to Reduce Complexities for Health Systems Delivering Value-Based Care
09/07/2018
Collaboration will create an EHR-agnostic offering, Maestro Advantage(TM), designed to help providers who participate in value-based arrangements, including Medicare Advantage and provider-sponsored health plans, [...]
Golden Leaf Holdings Appoints Rick Miller as Chairman of the Board of Directors and Announces New Board Members, John Varghese and Michael Crooke
09/07/2018
TORONTO, July 09, 2018 (GLOBE NEWSWIRE) -- Golden Lead Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]
Cutera Announces Appointment of Jason Richey as Chief Operating Officer
09/07/2018
BRISBANE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC., (Nasdaq:CUTR) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]
International Endeavors Corp. (IDVV) to Create Subsidiary Company in Canada
09/07/2018
TEMECULA, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC:IDVV) enters the Canadian cannabis market with plans to create a subsidiary company in response to the [...]
Hemispherx Files Positive Safety Report on Intranasal Use of Ampligen in Combination with FluMist Influenza Vaccine
09/07/2018
ORLANDO, Fla., July 09, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) announced the filing of a clinical study report on AMP-600, a Phase I/II trial of intranasal Ampligen® in combination with [...]
Diversicare announces retirement of Chief Executive Officer and appointment of Jay McKnight as new Chief Executive Officer
09/07/2018
BRENTWOOD, Tenn., July 09, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that Kelly J. Gill has retired as Chief Executive Officer of Diversicare effective July 6, 2018. [...]
Arcturus Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
09/07/2018
All Four Proposals Approved by Shareholders SAN DIEGO, July 09, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced that at its Extraordinary General [...]
Transactions under Novozymes’ stock buyback program
09/07/2018
Please read the full announcement in the attached PDF Attachment 2018_42_Stock_Buybackprogram_EN
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2018 After Market Close on July 16, 2018
09/07/2018
TUSTIN, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing [...]
Allscripts to release second-quarter 2018 financial results August 2
09/07/2018
CHICAGO, July 09, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months ended June 30, 2018, after the close of stock market hours on [...]
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114
09/07/2018
Triggers $4 million milestone payment under strategic collaboration with Nestlé Health Science REDWOOD CITY, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, [...]
Teneobio Announces Research Collaboration with Janssen to Develop Multispecific Antibodies for Oncology
09/07/2018
MENLO PARK, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Teneobio, Inc., a next generation multi-specific antibody therapeutics company, announced today the initiation of a research collaboration and licensing agreement [...]
VBI Vaccines to Participate in the 2018 Oppenheimer Boston Oncology Insight Summit
09/07/2018
CAMBRIDGE, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]
The American Health Council Welcomes Daniel Lichtstein, MD to Board of Physicians
09/07/2018
NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- The American Health Council welcomed Daniel Lichtstein, MD to its Board of Physicians for his outstanding contributions to the medical field. Currently serving as the Regional [...]
Endocyte and ITM Announce Long-Term Supply Agreement for No-Carrier-Added Lutetium-177
09/07/2018
Strategic Partnership Supports Commercialization Beyond Ongoing Phase 3 VISION Trial of 177Lu-PSMA-617 WEST LAFAYETTE, Ind. and GARCHING, Germany, July 09, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), and ITM [...]
Zafgen and the Foundation for Prader-Willi Research Announce PATH for PWS Natural History Study
09/07/2018
Information and data from study will advance understanding of medical history and medical events in people with PWS People living with PWS ages 5 and older and their caregivers are encouraged to participate BOSTON, July [...]
Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for Treatment of Ewing’s Sarcoma
09/07/2018
MADISON, Wis., July 09, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]

Pages